The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune priming with nivolumab followed by nivolumab and rituximab in first-line treatment of follicular lymphoma: The phase 2 1st FLOR study.
 
Eliza Anne Hawkes
Consulting or Advisory Role - Antigene (Inst); AstraZeneca; Bristol Myers Squibb (Inst); Gilead Sciences (Inst); Merck Sharpe & Dohme (Inst); Roche/Genentech (Inst)
Speakers' Bureau - Roche/Genentech; Roche/Genentech (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); Merck KGaA (Inst); Mundipharma (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Sze Ting Lee
No Relationships to Disclose
 
Geoff Chong
Consulting or Advisory Role - Bristol Myers Squibb Foundation (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Hutchison MediPharma (Inst); Isofol Medical (Inst); Merck Serono (Inst); Pharmacyclics (Inst); Regeneron (Inst); SERVIER (Inst)
 
Michael Gilbertson
No Relationships to Disclose
 
Andrew Grigg
Honoraria - MSD; Roche
Consulting or Advisory Role - Janssen; MSD Oncology; Novartis
 
Leonid Churilov
No Relationships to Disclose
 
Tineke Fancourt
No Relationships to Disclose
 
Colm Keane
Honoraria - Celgene; Gilead Sciences; MSD Oncology; Roche
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; MSD Oncology; Roche
Speakers' Bureau - Gilead Sciences; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; MSD Oncology; Roche
 
David Ritchie
No Relationships to Disclose
 
Rachel Koldej
Research Funding - crispr therapeutics (Inst)
Travel, Accommodations, Expenses - NanoString Technologies (Inst)
 
Rishu Agarwal
No Relationships to Disclose
 
Kate Manos
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Charmaine Smith
No Relationships to Disclose
 
Kristen Houdyk
No Relationships to Disclose
 
Joanne Hawking
No Relationships to Disclose
 
Allison Barraclough
Travel, Accommodations, Expenses - Roche